Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

52.41
+0.45000.87%
Post-market: 52.420.0100+0.02%19:59 EDT
Volume:2.40M
Turnover:125.62M
Market Cap:106.01B
PE:16.76
High:52.57
Open:51.35
Low:51.35
Close:51.96
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.71
T/O Rate:0.12%
Dividend:1.77
Dividend Rate:3.38%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.40
PE(LYR):14.03

Loading ...

GSK Climbs Tuesday, Outperforms Market

Dow Jones
·
Jun 24

GSK board members boost holdings with coordinated share purchases

TIPRANKS
·
Jun 23

GSK's Nuvalent Deal Could Be Rare Case of Profitable Oncology Acquisition -- Market Talk

Dow Jones
·
Jun 23

GSK Expands Treasury Stock Position with June Share Buybacks

TIPRANKS
·
Jun 22

GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial

TIPRANKS
·
Jun 19

GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib

TIPRANKS
·
Jun 19

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Jun 19

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GlobeNewswire
·
Jun 18

GSK, Spero Therapeutics Get FDA Approval for Utebzi in Complicated Urinary Tract Infections

MT Newswires Live
·
Jun 18

GSK, Spero Therapeutics announce FDA approval of Utebzi

TIPRANKS
·
Jun 17

GSK wins first US approval for oral carbapenem to treat complicated UTIs

TIPRANKS
·
Jun 17

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 17

Sector Update: Healthcare Stocks Advance in Afternoon Trading

MT Newswires Live
·
Jun 17

GSK Expands Share Buyback, Lifts Treasury Holding to 6.64% of Voting Rights

TIPRANKS
·
Jun 15

GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial

TIPRANKS
·
Jun 13

GSK announces momelotinib granted ODD from U.S. FDA, EMA

TIPRANKS
·
Jun 12

GSK's Clonal Myeloid Disorder Treatment Gets Orphan Drug Designation From US, European Regulators

MT Newswires Live
·
Jun 12

GSK’s momelotinib wins US and EU orphan status for rare VEXAS syndrome

TIPRANKS
·
Jun 12

Movement Alert|GSK Rises 3.06% in Regular Trading, Market Continues to Digest $10.6 Billion Nuvalent Acquisition as Oncology Strategy Gains Traction

Market Focus
·
Jun 12

TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 12